The main goal of this annual conference is to expose students, engineers, scientists and the overall academic and scientific communities to the greatest recent advances in the fields of Technology, Health and Biomedical Engineering taking place in some of the most prestigious research institutions. Each year different subjects are explored, always according to our audience's preferences. This is a 100% free event, so make sure you don't miss it!
In 2022, for the 14th WBME, we'll acknowledge the areas of Medical Robotics in Surgery, Proton Therapy in Oncology, Tissue Engineering in Organ development and, for the first time in a event like this, Biomedical Engineering in Veterinary Medicine will be explored! (8th October)
As for the practical workshops, we'll provide training in the fields of Microfluidics and Organs-On-Chip, 3D Printing for rehabilitation, Biomechanics and Computational Biophysics. (10th-14th October)
Furthermore, we'll have a session about the investigative work of an alumnus and we'll host a debate on Innovation in Science.
For eleven years, WBME was held only for one Saturday. On the 12th edition we expanded our event by adding practical workshops in the following week, in order to provide students with a more in-depth knowledge and to teach them some useful tools for both their academic and professional career. Plus, being a completely free event, it's the perfect opportunity for students to brush up their skills and learn a bit more!We hope this event will contribute to open new opportunities for research, from contact with people of the best science universities in the world, in this fascinating area that is changing the world of healthcare and life quality.
Prof. Joao Seco holds two MSc degrees, from the Univ. Lisbon & Univ. Paris (Solid State Physics and Material Science) and New Univ. Lisbon (Engineering of Medical Equipment), and a PhD in the University of London on Medical Physics.
Are you interested in proton beam-based radiotherapy? We have good news for you! On the 14th WBME, Prof. Joao Seco will be talking about it, particularly about understanding how this technique can be used on the treatment of lung cancer. Don't miss this opportunity to learn more!
Swipe left to know more about Prof. Joao Seco and his presentation.
Prof. Seco graduated with a PhD from the University of London, at the Institute of Cancer Research (ICR) and Royal Marsden Hospital in London, UK. He then went on to become an Assistant Professor of Radiation Oncology at Harvard Medical School in Boston, working at the Massachusetts General Hospital (MGH).
He then returned to Europe to work at the German Cancer Research Center, DKFZ in Heidelberg, heading up a new group dedicated to ion beam research and with the focus on 1) novel imaging technologies to reduce Bragg peak positioning errors in patients and 2) on investigating the mechanism of radiation triggered DNA damage via reactive oxygen species.
Prof. Joao Seco is presently the Chair of Medical Physics at the Department of Physics and Astronomy, Heidelberg University and is a member of the EFOMP Scientific Committee, representing the DGMP, German Society for Medical Physics.
Lung cancer remains the number one cancer killer among men and women worldwide. Because the lungs are located close to several critical normal structures in the body, it is challenging to deliver an adequate dose of radiation to a cancerous tumor while sparing these nearby normal tissues. That's where proton therapy has the advantage for many lung cancer and other thoracic cancer patients. Proton therapy advanced imaging technology allows the possibility to treat precisely the tumors within the lung and thoracic region, while maintaining the toxicity low. The talk will provide an overview of proton therapy, its delivering techniques and how these are used to treat lung cancer.
Prof. Alexander Seifalian's career spans decades in the fields of nanotechnology and regenerative medicine. His current projects have led to the development of cardiovascular implants using nanomaterials and stem cell technology, and the development of organs using tissue engineering and nanoparticles for detection and treatment of cancer.
Don't wait any longer! If your interest is tissue engineering this is the speaker you've been waiting for!
Swipe left to know more about Professor Alexander Seifalian and his presentation.
Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a year at Harvard Medical School working on development of vascular compliance graft and at Johns Hopkins Medical School looking at the treatment of liver cancer.
He published more than 687 peer-reviewed research papers and registered 14 UK and International patents. On editorial boards of 41 journals.
He supervised 121 PhD students, all successfully completed. He is currently co-founder of 3 companies, including NanoRegMed Ltd, working on the commercialisation of his research.
During his career, he has led and managed many innovative projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards' Winner of Most Innovative New Product 2012 for the “synthetic trachea”. He won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include the development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. Currently, he is working on the development and commercialisation of human organs using graphene-based nanocomposite materials and stem cells technology.
The potential for using smart nanomaterial and consequent research to replace damaged tissues has seen a quantum leap in the last decade. In 2010, two scientists in the UK realized they had isolated a single layer of carbon atoms on a scotch tape. Since then, graphene has captured the imagination of researchers due to its fascinating properties. Graphene considers as a wonder material, it is the strongest material on the planet, an order of 200 times stronger than steel, super-elastic and conductive. Graphene's carbon atoms are arranged into hexagons, forming a honeycomb-like lattice. The functionalized graphene oxide (FGO) with polyhedral oligomeric silsesquioxane (POSS) from butterfly wing are nontoxic and antibacterial. FGO has been used for drug and gene delivery, development of biosensor or in nanocomposite materials development of human organs. In my talk, I present and discuss our work on the application of FGO-POSS in development of medical sensors, drug, gene, and stem cells delivery, as well as the development of human organs with stem cells technology. The materials can be fabricated to human organs with the 3D printer or other fabrication methodologies. The scaffold from these materials is functionalized with bioactive molecules and stem cells technology, for the development of human organs. The data for the development of organs using these materials will be presented. In conclusion, the graphene, POSS bring new hope for gene, drug and stem cells delivery for repair and replacement of organs.
Passionate about medical devices and robotics, this speaker is a professional with a lot of experience, who graduated with a MSc at Instituto Superior Técnico and developed her thesis at RWTH Aachen University. Ana Sobreiro, will be on the 14th WBME, and you just can't miss her presentation!
Swipe left to know more about Ana Sobreiro and her presentation.
Ana Sobreiro is a Spinal Robotics Clinical Specialist at Medtronic. Her main responsibilities consist in leading the training and onboarding of new robotic centers in western Europe and closely supporting surgeons and surgical staff during their first robotic-guided surgeries. Prior to this role she was working as a Field Service Engineer for navigation, imaging and robotic systems. Ana holds a MSc in Biomedical Engineering from Instituto Superior Técnico and has developed her dissertation in RWTH Aachen in Germany. She lives in Lisbon although she spends most of her time flying all over Europe to support new robotic accounts.
Spine surgery is growing in frequency, with a continuing increase in the forecast of complex spine surgery. This upsurge represents a significant workload and challenge for health services. Spinal fusion is the gold standard treatment routinely used to prevent movement between the vertebrae and establish spinal stabilization. Even though accurate pedicle screw placement is critical to avoid complications, it is challenging to achieve with conventional techniques such as free-hand due to the complex anatomy of the spine and significant morphologic variability between individuals. The Mazor X Stealth Edition robotic guidance system offers the predictability of planning, the accuracy of robotic arm and the visibility of the navigation camera. It allows enhanced reproducibility and predictability through accurate execution of the preoperative plan, making surgeries safer and giving additional confidence to surgeons. Studies have shown that, compared to traditional techniques, the Mazor X allows for reduced radiation exposure, reduced length of stay and quicker post-op recovery.
Prof. Ricardo stated - "I have a great interest in neuroscience/neuroimaging and the translation of knowledge between Human Medicine and Veterinary Medicine, which is a huge challenge, but this is exactly what I like. Throughout my career, I have worked in healthcare, research, industry and education, having accumulated enormous knowledge that I use to create entrepreneurship and research projects in order to contribute to a better world."
This lecture will surely be a must-see event if these remarks motivated you!
Swipe left to know more about Prof. Ricardo and his presentation.
Prof. Ricardo Faustino started his education with a Master's deegree on Developmental Biology and Embriology in the Lusófona University but soon he went on to the Coimbra University to complete his PhD in Neuroimaging/Neuroscience. Afterwards, he took on an Integrated Master's Degree in Veterinary Medicine back at the Lusófona University.
One Health is based on an interdisciplinary approach to health problems in people and animals. In this context, comparative medicine emerges as an area of great importance, because it allows the study of a wide range of diseases, converting animals into natural models of the disease. Contrary to what happens in common translational research, in which genetically modified animal models are used in pre-clinical research, this new approach allows for a better use of resources and a bidirectional application of knowledge obtained in animals and humans, i.e. reverse translational medicine.
Currently One Health is focused on two projects: The first is the study of canine cognitive dysfunction syndrome, a neurodegenerative disease, similar to Alzheimer's disease in humans, as cognitive decline is associated with cortical atrophy, a progressive degeneration of brain tissue is associated with the development of amyloid plaques. The second project aims to carry out a comparative neuroimaging study between multiple sclerosis patients and dogs with canine disease granulomatous meningoencephalomyelitis, the most common neuroinflammatory disease that affects dogs, which mimics multiple sclerosis in humans. Neuroimaging techniques are on the rise in veterinary medicine, enabling the realization of brain morphometry studies and opening doors for the conduction of research works based on artificial intelligence and radiomics